Search results
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Buy at StockNews.com
ETF DAILY NEWS· 4 days agoBarclays lifted their price target on shares of Teva Pharmaceutical Industries from $17.00 to $20.00 and gave the stock an overweight rating in a report ...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 1 day agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Thousands of free opioid overdose reversal kits headed to Washington
The Columbian· 2 hours agoWashington residents can now order free life-saving opioid overdose reversal kits through the mail,...
FDA leaders talk adcomms, shortages
Politico· 5 hours agoMatthew Shields will become executive vice president of Teva Pharmaceutical Industries’ manufacturing and supply division next month. Alonzo Weems will ...
These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your...
Benzinga· 5 days agoToast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top...
Piper Sandler bullish on Teva stock on solid pipeline By Investing.com
Investing.com· 4 days agoOn Monday, Piper Sandler confirmed its Overweight rating on Teva Pharmaceutical Industries Limited...
FDA Panel to Weigh In on MDMA Approval; Parents Lost to Overdose; New APA President
MedPage Today· 3 days agoNews and commentary from the psychiatry world
Compugen Appoints David Silberman as Chief Financial Officer
FOX21 Colorado Springs· 2 days agoDavid will join Compugen from Oramed Pharmaceuticals Inc., where he served as Chief Financial Officer.
Here’s why UT, A&M unlikely to divest from Israel
The Longview News-Journal· 6 days agoAcross University of Texas System campuses and Texas A&M University, groups of students, faculty and staff have staged protests in solidarity with...
